A rAchnoid cysts are now diagnosed more frequent ly with the increasing use of intracranial imag ing. 2, 38, 75 Most arachnoid cysts are found in the anterior portion of the middle cranial fossa, although they may arise adjacent to any arachnoid membrane. 2 The nat ural history of arachnoid cysts is variable but frequently benign. 2 There are many reports of arachnoid cysts spon taneously enlarging, shrinking, or even resolving com pletely. 2, 28, 29, 56, 58, 63, 69, 76 Suprasellar cysts differ from other arachnoid cysts in several ways, making a separate analysis of these cysts worthwhile. A suprasellar location is relatively uncom mon for arachnoid cysts, representing only 1.6% of all arachnoid cysts in a recent large series of children under going MR imaging. 2 Surgical series involving arachnoid cysts, however, have typically found that suprasellar cysts represent between 8% and 15% of all cysts that required treatment. 13, 14, 17, 49, 52 The discrepancy in suprasellar cyst prevalence found in surgical series compared with radio graphic screening may suggest that suprasellar cysts are more likely to be treated surgically than cysts in other locations. Only 34 cases of SACs had been reported prior to the era of CT. 33 With the increasing availability of in tracranial imaging, there has been a recent increase in the number of these cysts receiving diagnosis and treatment.
Suprasellar arachnoid cysts may be recognized on MR imaging by their characteristic elevation of the floor of the third ventricle, often appearing just under the body of the lateral ventricle (Fig. 1) . Suprasellar cysts may present with characteristic clinical features due to compression of the adjacent structures. 13 They may pre sent with symptoms of hydrocephalus due to obstruction of the CSF pathways at either the foramen of Monro or, more commonly, at the level of the cerebral aqueduct. Suprasellar cysts may also present with visual impair ment due to compression of the optic apparatus or endo crine abnormalities due to mass effect on the pituitary stalk. 22, 33 Finally, head bobbing, or the "bobblehead doll" syndrome, is an unusual but welldescribed presentation of SACs. 4, 52 The unique features of the suprasellar location may favor a different surgical treatment compared with cysts in other locations. Endoscopic treatment is commonly employed for the treatment of arachnoid cysts. However, the proper site of fenestration of SACs continues to be de bated. Some surgeons favor VC, involving fenestration of the apical cyst membrane into the ventricle, while others recommend VCC, employing fenestration of both the api cal cyst membrane into the ventricle as well as the basal cyst membrane into the basal cisterns. 8, 12, 17, 74 Although the endoscopic treatment of these cysts has been increasingly reported, no single case series has included enough pa tients treated with both of these techniques to allow for an effective comparison of patient outcomes following VC and VCC fenestrations. In addition to presenting our own VCC outcomes, we have combined our results with data from prior reports of VCC and VC in an attempt to clarify this issue.
Methods

Data Collection
We retrospectively reviewed electronic records of all children 18 years of age or younger who were evaluated by the authors for an SAC between January 1, 1997, and February 1, 2007. All patients who were treated surgi cally underwent both preoperative and postoperative MR imaging. Demographic information, including age and sex, presenting symptoms, choice of surgery, and clini cal and radiographic outcomes were recorded for all pa tients. Data for any clinical changes that occurred during the followup period, including progression of symptoms, were collected from the clinical records.
Surgical Procedure
A standard VCC was performed in each case. The proper surgical technique for the VCC procedure has been previously described by Wang et al. 74 In each case, an introducer with a peelaway sheath was inserted through a standard right frontal approach to the frontal horn of the lateral ventricle. The introducer was removed and a ventriculoscope was placed into the ventricle. In every case, the floor of the third ventricle was apposed to the foramen of Monro. The floor was opened with en doscopic blunt biopsy forceps. Following this opening, the apical cyst wall was fenestrated with the forceps and the tip of the endoscope was advanced into the cyst. Any small vessels on the cyst lining were coagulated with a bipolar cautery device. Once the VC was performed, we then fenestrated the basal cyst wall into the prepontine cistern with the blunt biopsy forceps, thus completing a VCC. 25 The prepontine cistern and its contents, including the basilar artery, were visualized using the endoscope in every case.
Literature Review
A PubMed search using the search terms "suprasel lar cyst," "arachnoid cyst," "endoscopic cyst fenestration," "ventriculocystocisternostomy," and "ventriculocystosto my" was conducted to identify all reported cases of en doscopic VCC or VC in the Englishlanguage medical lit erature. Only those reports that specified the type of endo scopic fenestration (VCC or VC) and provided radiograph ic and clinical outcome were included in our analysis. We endeavored to include each treated patient only once in the survey, even if the operative outcome for that patient had been the subject of more than 1 report in the literature. We excluded reports of cysts due to neoplasms.
Statistical Analysis
Using SPSS version 18.0, we compared outcomes of endoscopic VC or VCC in an analysis of the combined data. Outcomes were statistically analyzed, using the need for further surgical treatment as a measure of treat ment failure. We separated groups according to the type of surgical treatment (VC or VCC) as well as the history of prior surgical treatment (first surgery versus reopera tions). Outcomes were compared using the Pearson un corrected chisquare test. A probability value < 0.05 was considered statistically significant.
Results
Clinical Presentation and Treatment
During the study period, 11 patients presented to our institutions with SACs that were believed to be symp tomatic and were treated using VCC as a first operation. Another 2 patients had been treated using shunt place ment prior to the first VCC attempt. Developmental delay and progressive macrocephaly were the most common preoperative symptoms (Table 1) . Precocious puberty was noted in 1 patient (Case 2) preoperatively. Hydrocephalus or ventriculomegaly was found preoperatively in most cases. No patient presented with the bobblehead doll syndrome. All patients were included in an outcome analysis. The mean age at surgery for the group undergo ing VCC as a first treatment was 3.5 years (range 1.7-7.4 years). No intraoperative complications were encoun tered. Postoperative MR imaging showed decompression of the suprasellar cyst in most cases ( Fig. 1 right) . One pa tient had persistent ventriculomegaly (Case 9) following a first treatment with VCC and was treated with a second VCC 1 month following the first operation. Of the 2 pa tients who had undergone shunt placement prior to VCC, one had an excellent outcome and is now shunt indepen dent, and the other patient underwent reimplantation of a shunt 1 month following the VCC. The 2 patients in this series who required reoperation following VCC had no postoperative change in the cyst following initial VCC. All other patients demonstrated a decrease in cyst size on postoperative imaging.
The mean clinical followup interval for the group undergoing primary VCC was 63 months (range 6-127 months). Of the 6 patients who presented with develop mental delay, all were judged to be developmentally nor mal at extended followup by the subjective evaluation of the parents and the surgeon. Precocious puberty was noted in 1 patient preoperatively but in 3 patients postoperatively (Cases 5, 6, and 9). No sodium regulation difficulties were noted in patients undergoing VCC as a first operation. A single patient who had been previously treated with a shunt developed transient diabetes insipidus following VCC. No patients experienced any new focal neurological deficits postoperatively.
Previous Studies of Endoscopic VC or VCC for SACs
Our search of the literature resulted in 14 published case reports or series involving 44 patients who underwent endoscopic VC for SACs that met our inclusion criteria and were included in the analysis. 7, 12, 14, 17, 21, 23, 24, 26, 27, 36, 39, 64, 66, 73 We identified 20 case reports or series that detailed outcomes for 75 patients following endoscopic VCC for SACs. To this latter group, we added 11 of our own patients who were treated with VCC as a first operation. Therefore, a total of 86 patients fol lowing VCC and 44 patients undergoing VC as a first op eration were included in the analysis (Tables 2 and 3) .
From 10 case reports or series, we identified 26 pa tients who underwent VC or VCC procedures that met all of the inclusion criteria but had undergone prior treatment with CPS, VPS, or other attempts at fenestration before the VC or VCC. 11, 14, 17, 21, 23, 24, 40, 41, 66, 67 Several of these cases were reported in larger series that also included VC or VCC as a first treatment. For example, in the report by Crimmins et al., 14 3 endoscopic fenestrations were per formed after prior failures. The series reported by Sood et al. 66 included 4 patients who underwent a VC as a first surgical treatment and 4 patients who had a history of prior surgical treatment. Similarly, in the series reported by Fitzpatrick and Barlow, 24 2 patients had a history of prior shunt placement and 5 patients underwent endo scopic fenestration as the first treatment. Fioravanti et al. 23 reported on 1 patient who had a primary endoscopic VC and 1 patient who had a shunt placement prior to VC. Finally, 5 patients in the series reported by Charalampaki et al. 11 had a prior surgical treatment and 6 other patients in their series underwent primary VCC. The results of VC or VCC following another prior surgical procedure are presented separately in Tables 4 and 5 , respectively.
Several reported cases of the endoscopic treatment of SACs were not included because the type of fenestration (VC or VCC) was not specified. 20, 30, 34, 53, 65 Some reported cases were also excluded if the outcome or followup information was not specified or because the outcome of endoscopic treatment of suprasellar cysts was not re ported separately from the outcome of a larger group in cluding either other types of cysts or other treatment mo dalities. 6, 45, 50, 65 Jones et al. 36 reported on 5 children who underwent surgical treatment for a suprasellar cyst, in cluding 1 endoscopic VC that was included and 4 patients who we excluded because they were treated by other means. Charalampaki et al. 11 reported on 13 patients who were treated surgically for SAC. Of these, 2 were treated with craniotomy and were excluded, and 11 were treated with VCC and were included in the analysis. We included 2 patients from Taburrini et al. 68 who underwent primary VCC, but excluded another patient from that series who underwent cystoperitoneal shunt placement at the same time as a secondary VC. One patient in the series report ed by Charalampaki et al. 11 required surgery for a newly diagnosed brain tumor several months following VCC; we did not classify this operation as a reoperation for the cyst. The report by Melikian et al. 44 was excluded because the cysts were associated with a neoplasm. Case reports by Schroeder and Gaab 61,62 and Nakamura et al. 47 were not included because a stent or shunt was placed at the same time as the VC. A case reported by RangelCastilla et al. 55 was excluded because an aqueductoplasty was per formed at the time of VC.
Several reports were excluded because they included patient outcomes that had been reported in other pub lished data from the same institution. 1, 16, 19, 29, 37, 40, 48, 52, 59, 61, 62 For example, the case report by Golash et al. 29 of an infant treated with VCC appears to refer to a patient who had been reported as part of a larger series by Kirollos et al. 40 In addition, the case series reported by O'Brien et al. 48 as well as Karabatsou et al. 37 appear to refer to several patients who were first reported by Kirollos et al. 40 We chose to include the latter case series because it provided the greatest amount of clinical detail on patients undergo ing VCC, but a single patient added in a later report by O'Brien was also included. 40, 48 The case report by Maiuri et al. 42 is included within a larger case series from the same institution 27 and that case report has been excluded. Finally, the series reported by Crimmins et al. 14 is the most recent report on SACs from Hopital NeckerEnfants Malades and is included in the analysis in place of prior published data from that hospital.
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Treatment Failure Following Endoscopic VC or VCC
The results of our survey of previously reported pa tients undergoing a first surgical treatment for an SAC are summarized in Tables 2 and 3 . Of the 44 patients under going VC as a first treatment, 7 (16%) required a second operation for a perceived treatment failure. In contrast, only 7 (8%) of 86 patients undergoing endoscopic VCC required a second operation for a perceived treatment failure. The lessfrequent need for reoperation following VCC compared with VC in those undergoing the first sur gical treatment was found to lack statistical significance (p = 0.2).
All previously reported patients who underwent endo scopic VC or VCC following another surgical procedure were analyzed separately. We identified 5 reports 14, 23, 24, 41, 66 including 11 patients that described outcomes following endoscopic VC after a prior surgical procedure (Table 4) . We identified 6 reports 11,17,21,23,40,67 including 15 patients that described outcomes following endoscopic VCC after a prior surgical procedure (Table 5) . To this group, we added 2 of our own patients who had undergone VCC following prior treatment with a shunt. Of the 11 patients who were treated with endoscopic VC following another surgical procedure, 4 (36%) required yet another surgical treatment. In contrast, only 2 (12%) of the 17 patients who underwent VCC following another surgical procedure re quired any further surgical treatment.
Finally, we compared the need for further surgical treatment between all reported patients who were treated with either VC or VCC, without regard to any prior surgi cal treatment. This analysis included 55 patients follow ing VC and 103 patients following VCC. Eleven (20%) of * CN = cranial nerve. † The patient did undergo reoperation but a patent basal fenestration with cyst decompression was confirmed at the time of the second surgery. the VC patients required reoperation compared with only 9 (9%) of the VCC patients. This difference was statisti cally significant (p = 0.04). The relative risk for retreat ment when treated with VC compared with VCC was 2.3 (95% CI 1.0-5.1).
Discussion
Surgical options for the treatment of SACs include placement of a CPS, 13, 54 open craniotomy via a transcal losal or subfrontal approach, 33, 36, 46, 54, 57 a transsphenoidal approach with or without endoscopic assistance, 9,10 ven triculocystic stent placement, 5 and endoscopic fenestra tion. 8, 12, 17, 40, 74 Shunt placement is no longer favored be cause of the need for foreign body implantation and the concomitant risk of shunt infection, failure, or lifelong shunt dependence. 3, 41, 43, 49, 51, 55, 65 Open surgical approaches for fenestration of arachnoid cysts may avoid the risks as sociated with longterm shunt placement, but may be as sociated with a relatively higher surgical morbidity com pared with endoscopic procedures. 32, 62 In recent years, endoscopic fenestration has emerged as a safe and highly effective treatment for SACs in children. 74 A number of different surgical techniques have been advocated for endocopic fenestration of SACs. Some have advocated an endoscopic VC, which involves the fenes tration of a SAC into the ventricular system without a concurrent basilar fenestration (a cisternostomy) into the prepontine cistern. 12, 39, 52, 65 Many surgeons have suggested that a VC and a cystocisternostomy, or VCC, affording both an apical as well as a basal fenestration in the cyst lining, may be preferable to VC alone. 14, 17, 74 There have been several reported cases in which an apical fenestra tion has closed postoperatively leading to a failure of the cyst decompression. 8, 14, 17 Fenestration of both apical and basal cyst membranes theoretically reduces the risk of failure from this eventuality. Crimmins et al. 14 found that in large cysts associated with aqueduct obstruction, VC was only effective in 25% of cases but VCC was effec tive in every case. On the basis of this finding, Crimmins and colleagues advocated the use of VCC in preference to VC. Because the surgical treatment of SACs is relatively uncommon, even in referral centers, previously published case series have not included enough patients to statisti cally compare the efficacy of these techniques. For this reason, we attempted to perform a simple analysis that combined all prior published experience as well as results from our own patient series.
Given the known association of SAC with ventricu lar outlet obstruction, it is possible that fenestration into the ventricular system alone, as is done in a VC, is not enough to guarantee sufficient egress of CSF though the ventricular pathway. 55 In addition to ventricular outflow obstruction resulting from direct mass effect of the arach noid cyst on the cerebral aqueduct, RangelCastilla et al. 55 documented other ventricular anomalies associated with arachnoid cysts that can lead to outflow obstruction. They found 5 instances of aqueductal obstruction due to a thin membrane covering the aqueduct in patients with a concomitant arachnoid cyst in the Sylvian fissure, the interhemispheric fissure, or in 1 case, in the suprasellar region. 55 In contrast to VC, a VCC allows the cyst fluid to bypass the ventricular system and enter the cisterns di rectly. 74 Despite increasing support for VCC, prior reports did not by themselves include a sufficient number of 10, 18 Due to the small number of patients who have been treated using that technique, we were unable to com pare that approach to VCC or VC. Given the established success of the VC or VCC, we do not advocate the trans nasal approach for these cysts unless more compelling data on its efficacy can be presented.
Our analysis does not take into account potentially relevant differences in surgical technique beyond the most basic distinction between a VC and a VCC. This may fail to account for outcome differences that result from individual variation in surgical technique. For in stance, Choi et al. 12 perform a VC rather than a VCC, but make a 10mm or greater opening in the apical cyst wall. It is unclear whether this very large fenestration may con tribute to the excellent outcomes for VC reported by that group. Similarly, Buxton et al. 7 advocate the additional step of endoscopically opening the septum pellucidum during VC if the lateral ventricles are asymmetrical. Finally, several groups have incorporated extensive co agulation of the apical portion of the arachnoid cyst dur ing the VC procedure in an effort to restore normal CSF pathways within the ventricular system. 12, 41, 66 Based on the small numbers of patients treated with any of these specific techniques, as well as the lack of surgical pro cedure detail provided in the published reports, it was impossible in the statistical analysis to account for these differences in surgical technique as well as any differ ences in the adequacy of the fenestrations that they create.
Our analysis of the literature may have been influ enced by reporting bias because it is possible that groups were more likely to report excellent outcomes rather than poor outcomes. We hope that this reporting bias was evenly distributed among the VC and VCC groups, but we acknowledge that there is no way to be certain that this was the case. Given the prior reports of late treatment failures following endoscopic fenestration of arachnoid cysts, longterm followup is essential for any true deter mination of efficacy.
14, 17 The results of our own surgical series with a long followup interval indicate that VCC for the treatment of SACs is clinically durable. Nevertheless, the potential for underestimating complications or treat ment failures exists in any analysis in which the followup interval is less than the time in which there is a potential for treatment failure.
Conclusions
We conclude from our analysis that VCC is an effec tive and durable treatment for symptomatic SACs.
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